Ex Parte Kelm et al - Page 2

                 Appeal 2006-1223                                                                                      
                 Application 10/214,009                                                                                

                                                   DISCUSSION                                                          
                        “The present invention relates to compositions comprising short and                            
                 long chain fatty acids which are suitable for oral administration, wherein the                        
                 compositions are useful for the management of body weight . . . effected via                          
                 induction of satiety” (Specification 3-4).                                                            
                        Claims 1 and 17 are representative of the claimed subject matter:                              
                        1.  A composition comprising:                                                                  
                               (a) a short chain fatty acid component selected from the                                
                                      group consisting of acetic acid, propionic acid, butyric                         
                                      acid, esters thereof, salts thereof, and mixtures thereof;                       
                                      and                                                                              
                               (b) a long chain fatty acid component selected from the                                 
                                      group consisting of long chain fatty acids, non-glyceryl                         
                                      esters of long chain fatty acids, and mixtures thereof;                          
                                      wherein the compositions are suitable for oral                                   
                               administration to a mammal; and wherein the ratio of long                               
                               chain fatty acid component to short chain fatty acid component                          
                               is about 10:1 or less, by weight of the long chain fatty acids to                       
                               the short chain fatty acid.                                                             
                        17.  The composition according to Claim 1 further comprising fiber.                            
                        In response to the Examiner’s requirement for an election of species,                          
                 Appellants elected calcium propionate as the short chain fatty acid (SCFA)                            
                 component of the composition, and ethyl oleate as the long chain fatty acid                           
                 (LCFA) component (Appellants’ Response, submitted May 13, 2004).  It                                  
                 appears that the Examiner focused on this combination exclusively.  We will                           
                 do likewise.                                                                                          


                                                          2                                                            

Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next

Last modified: September 9, 2013